Mostrando 10 resultados de: 22
Publisher
Bionatura(4)
Biotecnologia Aplicada(3)
Electronic Journal of Biotechnology(2)
Molecular Immunology(2)
Cancer Research(1)
Área temáticas
Enfermedades(17)
Farmacología y terapéutica(13)
Microorganismos, hongos y algas(9)
Bioquímica(5)
Fisiología humana(3)
Área de conocimiento
Inmunología(8)
Biotecnología(6)
Bioquímica(4)
Enfermedad cardiovascular(4)
Ciencia de materiales(2)
Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction
ArticleAbstract: Therapies aimed at enhancing cardiomyocyte survival following myocardial injury are urgently requirePalabras claves:Cardioprotection, Growth-hormone-releasing peptide 6 (GHRP6), infarction, Ischaemia, myocardium, Necrosis, Oxidative StressAutores:Alba J., Berlanga-Acosta J., Cibrian D., Dominguez H., Garcia D., Guevara L., Guillén-Nieto G.E., López-Mola E., López-Saura P.A., Perez B., Rodriguez A., Santiago Nelson Vispo, Seralena A.Fuentes:scopusHybrid immunity: The immune response of COVID-19 survivors to vaccination
ReviewAbstract:Palabras claves:Autores:Marlon Alexander Gancino Guevara, Marlon Gancino, Santiago Nelson VispoFuentes:googlescopusExpression and Characterization of Human Vascular Endothelial Growth Factor Produced in SiHa Cells Transduced with Adenoviral Vector
ArticleAbstract: The vascular endothelial growth factor (VEGF) is an essential factor to pathologic angiogenesis. DisPalabras claves:Adenoviral vector, ECV-304 cells, HUVEC, Vascular permeability, VEGF 121Autores:Aedo G., Camacho F., Castillo C., González-Chavarría I., González-Horta E.E., Mansilla R., Parra N.C., Sanchez O., Santiago Nelson VispoFuentes:scopusForms and methods for interferon’s encapsulation
ReviewAbstract: Interferons (IFNs) are cytokines involved in the immune response that act on innate and adaptive immPalabras claves:Antiproliferative, antiviral, Drug delivery system, Encapsulate IFNs, formulation, IFN-α, IFN-β, IFN-γ, Immunomodulator, interferons, Liposomes, Microparticles, Nanoparticles, Pegylation, Polymeric micellesAutores:Leandro Santiago Padilla, Parra N.C., Santana S.P., Santiago Nelson Vispo, Thelvia I. Ramos Gómez, Toledo Alonso J.R., Villacis-Aguirre C.A.Fuentes:googlescopusGangliosides, Ab1 and Ab2 antibodies. I. Towards a molecular dissection of an idiotype-anti-idiotype system
ArticleAbstract: This report is focused on the molecular basis for the interaction of a monoclonal antibody (mAb) andPalabras claves:Anti-idiotypic antibodies, H-CDR, N-Glycolyl-gangliosidesAutores:González M., López-Requena A., Mateo de Acosta C., Moreno E., Pérez R., Puchades Y., Santiago Nelson Vispo, Talavera A., Vázquez A.M.Fuentes:scopusGene therapy using a plasmid that expresses the VEGF<inf>121</inf> for the treatment of the critical ischemic cardiophaty
ArticleAbstract: Here we report, for the first time in Cuba, the use of gene therapy to evaluate the positive therapePalabras claves:Clinical study, Gene therapy, Vascular endothelial growth factorAutores:Batista J.F., Betancourt B.Y., Chaos N., Chil R., Coca M., Fleites G., García A., García E., Garzón E., González M.J., González N., González R., Guevara L., Guillén-Nieto G.E., Méndez T., Milán R., Naffe M., Quián Y.P., Reina C., Santiago Nelson Vispo, Senra G., Seralena A., Suárez L.R., Vazquez R., Villar A.Fuentes:scopusGene therapy with a plasmid expressing the VEGF<inf>121</inf> for the treatment of critical ischemic cardiopathy
ArticleAbstract: Here we report, for the first time in Cuba, the evaluation of the positive therapeutic action and saPalabras claves:Autores:Batista J.F., Betancourt B.Y., Chaos N., Chil R., Coca M., Fleites G., García A., García E., Garzón E., González M.J., González N., González R., Guevara L., Guillén-Nieto G.E., Méndez T., Milán R., Naffe M., Quián Y.P., Reina C., Santiago Nelson Vispo, Senra G., Seralena A., Suárez L.R., Vazquez R., Villar A.Fuentes:scopusDisplay technology on filamentous phage in the searchfor anti-infective biological agents
ReviewAbstract: Introduction: The causes of antibiotic resistance are complex. The phage display technology has beenPalabras claves:Antibodies, Bacteriophages, Biopaning, Combinatorial libraries, Infectious diseases, Peptides, Phage display technologyAutores:Antúnez M.P., Camacho F., Ramos O.S., Santiago Nelson Vispo, Toledo R.Fuentes:scopusDisplaying human interleukin-2 on the surface of bacteriophage
ArticleAbstract: Previous attempts to produce active human Interleukin-2 (hIL-2) in E. coli have failed, due to its aPalabras claves:Interleukin-2, pelB, phage display, Secretion in E. coliAutores:Araña M.J., Callejo M., Chinea G., Gavilondo J.V., Ojalvo A.G., Santiago Nelson Vispo, Santos-Savio A.Fuentes:scopusA monoclonal antibody against NeuGc-containing gangliosides contains a regulatory idiotope involved in the interaction with B and T cells
ArticleAbstract: P3 (IgM-κ) is a monoclonal antibody (mAb) reacting with N-glycolyl neuraminic acid (NeuGc)-containinPalabras claves:H-CDR3, Idiotype, Monoclonal antibody, N-Glycolyl neuraminic acidAutores:Mier E., Perez A., Rodríguez R., Santiago Nelson Vispo, Vázquez A.M.Fuentes:scopus